185 related articles for article (PubMed ID: 23136730)
1. [Study of the effects of vinpocetin on cognitive functions].
Valikovics A; Csányi A; Németh L
Ideggyogy Sz; 2012 Mar; 65(3-4):115-20. PubMed ID: 23136730
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions].
Valikovics A
Ideggyogy Sz; 2007 Jul; 60(7-8):301-10. PubMed ID: 17713111
[TBL] [Abstract][Full Text] [Related]
3. [The use of vinpocetine in chronic disorders caused by cerebral hypoperfusion].
Horváth S
Orv Hetil; 2001 Feb; 142(8):383-9. PubMed ID: 11263076
[TBL] [Abstract][Full Text] [Related]
4. [Comment on the paper by A. Valikovics et al. "The effect of vinpocetin on cognitive function" published in the issue 3-4 of this year].
Gyuris J
Ideggyogy Sz; 2012 May; 65(5-6):215. PubMed ID: 22724292
[No Abstract] [Full Text] [Related]
5. [The role of vinpocetine in the treatment of cerebrovascular diseases based in human studies].
Bagoly E; Fehér G; Szapáry L
Orv Hetil; 2007 Jul; 148(29):1353-8. PubMed ID: 17631470
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) Trial.
Zhang W; Huang Y; Li Y; Tan L; Nao J; Hu H; Zhang J; Li C; Kong Y; Song Y
Clin Drug Investig; 2016 Sep; 36(9):697-704. PubMed ID: 27283947
[TBL] [Abstract][Full Text] [Related]
7. [Vinpocetin in neurological diseases].
Szapáry L; Késmárky G; Tóth K; Misnyovszky M; Tóth T; Balogh A; Nagy K; Németh GY; Fehér G
Ideggyogy Sz; 2012 Nov; 65(11-12):387-93. PubMed ID: 23289173
[TBL] [Abstract][Full Text] [Related]
8. Transcranial Doppler assessment of cerebral vasomotor reactivity in evaluating the effects of vinpocetine in cerebral small vessel disease: a pilot study.
Jovanović ZB; Pavlović AM; Pekmezović T; Mijajlović M; Covicković NS
Ideggyogy Sz; 2013 Jul; 66(7-8):263-8. PubMed ID: 23971358
[TBL] [Abstract][Full Text] [Related]
9. [Complex application 2-ethyl-6-methyl-3-hydroxypyridine-succinate and vinpocetine in cerebrovascular disorder.].
Solovyeva EY; Karneev AN; Chekanov AV; Baranova OA; Choi IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):103-108. PubMed ID: 28638040
[TBL] [Abstract][Full Text] [Related]
10. The safety and lack of efficacy of vinpocetine in Alzheimer's disease.
Thal LJ; Salmon DP; Lasker B; Bower D; Klauber MR
J Am Geriatr Soc; 1989 Jun; 37(6):515-20. PubMed ID: 2715559
[TBL] [Abstract][Full Text] [Related]
11. [The use of the combined drug vinpotropil at early stages of cerebrovascular insufficiency].
Zakharov VV; Lokshina AB; Stakhovskaia LV; Timerbaeva SL; Lagoda OV
Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):76-8. PubMed ID: 18686371
[No Abstract] [Full Text] [Related]
12. [Vinpotropile in the treatment of cerebral vascular diseases].
Filimonov VA; Kliueva VN; Kondrasheva IN
Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(2):58-60. PubMed ID: 18689000
[No Abstract] [Full Text] [Related]
13. Acute and chronic effects of vinpocetine on cerebral hemodynamics and neuropsychological performance in multi-infarct patients.
Kemény V; Molnár S; Andrejkovics M; Makai A; Csiba L
J Clin Pharmacol; 2005 Sep; 45(9):1048-54. PubMed ID: 16100299
[TBL] [Abstract][Full Text] [Related]
14. Vinpocetine in the treatment of poststroke cognitive dysfunction: A protocol for systematic review and meta-analysis.
Liu Y; Yin Y; Lu QL; Dan Y; Xu MS; Song G; Li C
Medicine (Baltimore); 2019 Feb; 98(6):e13685. PubMed ID: 30732122
[TBL] [Abstract][Full Text] [Related]
15. [Use of cavinton in neuropaediatrics].
Studenikin VM
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(12):63-4. PubMed ID: 15847328
[No Abstract] [Full Text] [Related]
16. Role of vinpocetine in cerebrovascular diseases.
Patyar S; Prakash A; Modi M; Medhi B
Pharmacol Rep; 2011; 63(3):618-28. PubMed ID: 21857073
[TBL] [Abstract][Full Text] [Related]
17. [An effect of vinpocetine (cavinton) on endothelium function in patients with chronic cerebral ischemia].
Vaizova OE; Vengerovskiĭ AI; Alifirova VM
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 16():46-50. PubMed ID: 18196635
[TBL] [Abstract][Full Text] [Related]
18. Asymptomatic ischemic cerebrovascular disorders and neuroprotection with vinpocetine.
Hadjiev D
Ideggyogy Sz; 2003 May; 56(5-6):166-72. PubMed ID: 12861957
[TBL] [Abstract][Full Text] [Related]
19. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
[TBL] [Abstract][Full Text] [Related]
20. [A multicenter program on assessment of efficacy and safety of a new therapeutic scheme for patients with chronic cerebrovascular insufficiency].
Skoromets AA; Tanashian MM; Chukanova EI; Petrova EA; Spirin NN; Nikonov AA; Peverennova IE; Levin IaI
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5 Suppl 2):44-8. PubMed ID: 19894300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
